Both in Pharmaceuticals
ADARx Pharmaceuticals vs Stoke Therapeutics
Over the past year ADRX returned −22.9% and STOK returned +5.6%; their daily moves had a correlation of 0.13.
ADRX −22.9% STOK +5.6%Growth of $1, one year, split-adjusted
| Metric | ADRX | STOK |
|---|---|---|
| Price | $14.91 | $26.20 |
| Market cap | $1.59B | $1.71B |
| Today | +12.11% | −5.62% |
| 1 month | −16.4% | +12.6% |
| 6 months | — | −16.5% |
| Year to date | — | −17.5% |
| 1 year | — | +4.3% |
| Revenue growth (YoY) | — | +5.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −654.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 60.7× |
| Net cash | — | $319.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 49.8% |
| Short % of float | 3.4% | 19.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).